Scientific News Boston Scientific S Upside With Cardiology Devices Drives Momentum
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific S Upside With Cardiology Devices Drives Momentum is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific Q3: Operational Improvements Warrant An Upgrade To A Buy
Boston Scientific posts strong Q3 growth and upgrades 2025 outlook. See why BSX stock is rated Buy and what drives its leadership. Read More
Boston Scientific raises 2025 organic growth guidance to 15.5% amid WATCHMAN and EP momentum
Q3 2025 Management View CEO Michael Mahoney reported, “In third quarter '25, total company operational sales grew 19% and organic sales grew 15%, exceeding the high end of our guidance range of 12% to ... Read More
Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost
Boston Scientific (BSX) stock rises as the company beats Q3 forecasts and raises full-year outlook thanks to strong cardiology sales. Read more here. Read More
Cardiovascular devices lift Boston Scientific’s Q3 results
Boston Scientific reported $5.065 billion in net sales for the third quarter of 2025, driven largely by demand for cardiovascular devices. The company’s cardiovascular segment grew 22.4% year over ... Read More
Boston Scientific Jumps On Strong Guidance, Heart Devices Fuel Topline Growth
Boston Scientific Q3 revenue hit $5.07 billion, beating forecasts. The company raised its full-year guidance based on strong segment growth. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus